| 3.88 Delayed Data As of Sep 13 |  -0.08 / -2.02%Today’s Change | 1.97 Today|||52-Week Range 18.50 | -46.85% Year-to-Date |
| Previous close | 3.96 |
| Today’s open | 4.07 |
| Day’s range | 3.82 - 4.26 |
| Volume | 5,457,338 |
| Average volume (3 months) | 6,570,720 |
| Market cap | $878.4M |
| Earnings growth (last year) | +49.45% |
| Earnings growth (this year) | -25.23% |
| Earnings growth (next 5 years) | -4.40% |
| Revenue growth (last year) | -15.04% |
| P/E ratio | NM |
| Price/Sales | 0.55 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| KPTIKaryopharm Therapeut... | +0.45 | +4.25% |
| HSKAHeska Corp | +2.85 | +4.44% |
| MISTMilestone Pharmaceut... | +0.16 | +0.72% |
| CLLSCellectis SA | +0.07 | +0.56% |
| Next reporting date | November 7, 2019 |
| EPS forecast (this quarter) | $0.52 |
| Annual revenue (last year) | $2.9B |
| Annual profit (last year) | -$1.0B |
| Net profit margin | -32.63% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Paul V. Campanelli |
Chief Operating Officer & Executive Vice President Terrance J. Coughlin |
Corporate headquarters Dublin, Dublin |
